About LSPOR

LSPOR is the Lebanon Chapter of ISPOR, the International Society for Pharmaco-economics and Outcomes Research.

ISPOR is the Leading Global Professional Society in Pharmacoeconomics Founded in 1995 as an international multi-disciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) aims to advance the policy, science, and practice of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes.

lsporbanner

LSPOR is aiming to promote health economics and outcomes research (HEOR) to become the tool for evidence-based decision makings in heath technology assessment; and supporting the next generation of researchers, by providing forums and opportunities both for learning and for exchanging important new ideas and approaches.

LSPOR will help to drive the discussion for creating incentives in health care systems to achieve better outcomes, and creating the tools and systems to measure performance
As a membership organization of individuals and not companies, LSPOR offers an unbiased perspective in local conversations and acts as the catalyst for dialogue and information-sharing on key topics. Our organization is a neutral platform dedicated to advancing key discussions and knowledge across all key stakeholders.

Quality and integrity are the hallmarks of LSPOR, and we will continue to prove that through our conduct, meeting, educational activities and various initiatives. I encourage future members to get involved—to volunteer and to contribute their expertise in advancing the mission and goals of our Society. Thus I invite you to go over the membership brochure and explore on the opportunities and conditions to join LSPOR and gain an opportunity to network with professionals in your field or similar fields that will increase your awareness and scientific knowledge in pharmacoeconomics/health economics and patient health outcomes